This notice is a reminder to the NIH and AHRQ applicants and recipient community that applicants must use FORMS-F application packages for the due dates on or after May 25,2020. For those submitting application packages for due dates on or before May 24, 2020 you need to still use FORMS-E.
Please be aware the FORMS-F for the “most commonly accessed” Parent Announcements are now available. See below:
Be aware there has been several changes when it comes to the proposal submission processes. See below:
If you are submitting a proposal to an external agency, one should use the University’s Cayuse system. Information pertaining to the Cayuse Research Suite can be accessed: https://research.wayne.edu/spa/cayuse. Note all proposals require Sponsored Program Administrations (SPA) approval prior to submission to the funding agency.
They have also issued interim guidance (NOT-OD-19-099) on salary limits for NIH grants and cooperative agreements. The direct salary limitation follows Executive Level II of the Federal Executive pay scale, which is currently $192,300. The Ruth L. Kirschstein National Research Service Award predoctoral and postdoctoral stipend levels and tuition/fee are described in NOT-OD-19-036.
If you need guidance on applying the NIH salary cap in your proposals, here is the website: http://somresearch.med.wayne.edu/pre-award-prep under “Budget” then select “Accounting for the Salary Cap”. If you have any questions, feel free to email RAS@med.wayne.edu
Who has the responsibility for verifying and ensuring “other
support disclosures” in applications to the sponsor is accurate? If you answered-the institution applying for
and receiving the funds, you are correct.
“Other support” is not to be confused with the “research
support” section within the bio-sketch. Refer
to this link https://grants.nih.gov/grants/forms/othersupport.htm
for guidance as to what info the PI is required to provide in an Other Support
as well as samples. Administrators should
work in tandem with the PI to ensure all of the active and pending funding sources
are accurately referenced as Sponsors use the “Other Support” to make sure
there is no budgetary, scientific or commitment overlap. Note there can be serious ramifications for
inaccurately reporting other support information, especially when the sponsor
is federal, since it involves the use of U.S. taxpayer funds. The severity and length of time for noncompliance
determines the type of sanctions received, such as termination of the award. The link for the NIH Extramural Nexus has
been included for further reading on the subject (https://nexus.od.nih.gov/all/2019/07/11/clarifying-long-standing-nih-policies-on-disclosing-other-support/)
Your principal investigator has answered yes on the export
control compliance section in Cayuse.
Did you remember to add Export Control to the Approving Units page? This is an important section that will
protect the university and the researcher from severe criminal and or civil
penalties, because of unintentional noncompliance to federal regulations. Export Control is not a topic that is widely
discussed or thought about when a principal investigator begins writing a
proposal and the administrator starts assembling the application package.
The word “export” will cause many to believe you’re talking
about sending items outside the United States, but this is not the case and it
may also include consulting, training, and speaking at conferences. The code of federal regulations under the
Export Administration Regulations (EAR) defines export as, “an actual shipment
or transmission of items out of the United States”, which also includes
releasing or transferring. Most don’t
consider that something can be exported via auditory, visual, verbal or
electronic means. This is the reason
that our Export Control office exists in order to prevent the innocent
violation of any federal regulations. If
you want to learn more about export compliance click on the link https://research.wayne.edu/integrity/export-control
and take note there is an CITI Export Control Module offered by WSU.
NIH advertises available funding for grant support through
funding opportunity announcements (FOAs). One can search for an announcement
specific to their area of interest/expertise or apply to one of the generic NIH
announcements. FOAs can be accessed
via the federal-wide portal – Grants.Gov or via the NIH Guide for Grants and
Please be sure to read the FOA very carefully as there may
be additional instructions that refer you to select a specific “companion
funding opportunity” within the Parent Announcement. For example, applications that include
clinical trials must be submitted in response to an announcement that allows
clinical trials; the same applies to applications that do not allow clinical
You want to avoid a situation where you’re close to completing the application only to find out the “error” that keeps arising is the result of downloading the wrong application. If you want to know more about “Understanding the Funding Opportunities”, NIH has a website that provides you with some great tips to be aware of.
If you have any questions, don’t hesitate to contact the SOM
Research Administrative Services (RAS) Office via RAS@med.wayne.edu
Please check your budgets! The Office of Personnel
Management has recently released new salary levels for the Executive Pay Scale.
Effective January 6, 2019, the
salary limitation for Executive Level II is $192,300.
If you are awarded with a budget that did not include the
new cap, you’re welcome to rebudget using the new cap within the limitations of
the award, but no new funds will be given by the agency. If you’re in the
process of working on proposals for any upcoming deadlines, now is a great time
to revise those budgets and any associated cost sharing.
There is encouragement from federal sponsors and Wayne State University’s (WSU) Office of Vice President for Research to conduct more team science research. With this movement towards team science, we’re seeing more proposals with other Schools/Colleges/Institutes such as CLAS and Engineering to name a few. Reminder, when building budgets and rosters, the personnel section should include every WSU person working on the project. This allows the participating departments to see what faculty/staff are committed to projects outside of their primary departments. Submitting within 3 – 7 days of the deadline will allow ample time for E-Visions departmental approvals, before moving on to Sponsored Programs as the final approver.
According to the above notice and guidelines the mathematical inequality symbols are included within the acceptable/supported Unicode Character Set. However, it has come to our attention that usage of these particular symbols may delay if not prevent the successful submission of an NIH application. While the use of these symbols will not result in error notices within the University’s Cayuse system, the problem is encountered when the application is routed from Grants.gov to eRA Commons.
when entering text where these symbols may be used it is suggested that their
meaning be written in longhand, i.e.
To bring you up to speed, the use of OnCore is School of Medicine policy on all studies with human subjects. It’s canon. We need to see that you’ve accounted for this in your submissions. The use of OnCore is mandated to help track human subjects populations here at Wayne State and, until recently, OnCore fees were to be budgeted into all studies with human subjects. While a good portion of budgets still need to reflect this, the mandate has been altered slightly.
Going forward, investigators applying for funding from non-corporate (i.e., federal and foundation) sources no longer need to include OnCore fees in their budget. They DO, however, need to ensure that their protocol and human subjects populations are registered in the OnCore database at time of award. Please note that proposals and contracts with corporate entities (i.e. pharmaceuticals, biomarkers, and devices) that exceed $50,000 in total direct costs WILL still need to include OnCore fees in their budgets. For all funded studies (corporate and non-corporate) that wish to use OnCore as their Clinical Research Management tool, respective OnCore fees will apply.
This should bring some relief to federal and foundational proposal budgets that are often subject to caps. To reiterate, however: your human subjects populations must still be registered with OnCore (this includes non-clinical trial populations). Please be sure to contact the Clinical Research Services Center (CRSC) for assistance in registering your population, or for questions regarding study management capabilities.